How Much Weight a Month Can You Lose on Wegovy?

Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and activating brain centers that control hunger, helping many people shed significant weight when combined with lifestyle changes. Clinical trials have shown that patients typically experience measurable weight reduction within the first 30 days of starting treatment. Understanding realistic monthly progress helps set expectations and track whether your current dose is working for your goals.

Average Monthly Weight Loss on Semaglutide

Clinical trial data from the Novo Nordisk STEP program demonstrated that participants lost an average of 5 to 10 pounds per month across the first 16 weeks of treatment. This makes semaglutide one of the most effective medications for consistent, predictable weight reduction. The pace slows slightly over time, but weight loss typically continues for the full duration of therapy.

Individual results depend heavily on starting weight, adherence to injections, and dietary habits. Patients who weigh more at baseline often see larger absolute weight loss in the first month. Those who maintain a calorie deficit alongside semaglutide therapy see faster and more sustained results than those relying on medication alone.

How Dose Timing Affects Monthly Progress

Semaglutide treatment begins at a low starting dose that is gradually increased every four weeks until reaching the maintenance dose. During the initial titration phase (weeks 1–4), weight loss may be slower because your body is still adjusting to the medication. Once the dose reaches therapeutic levels, weight loss typically accelerates in months two and three.

PlexusDx delivers compounded semaglutide at a flat monthly rate, meaning your dose may need to go up, but your price won't. This pricing structure removes the barrier many patients face when advancing to higher doses that deliver better results. Dose increases are made based on your response and goals, not your budget.

Genetic Factors That Shape Your Monthly Results

Your genetic makeup influences how quickly semaglutide works and how much weight you're likely to lose each month. Variants in genes like FTO, and MC4R affect how your body responds to appetite-suppressing signals. Two patients on identical doses can experience different weight loss rates due to these underlying genetic differences.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Realistic Expectations Beyond the First Month

The most dramatic weight loss usually occurs in months one through three, when appetite suppression is strongest and medication effects are most novel. After three months, monthly weight loss typically levels to 2 to 4 pounds, which is still considered excellent progress by medical standards. By six months, many patients reach a weight-loss plateau unless the dose is increased or lifestyle changes are intensified.

Long-term success requires viewing semaglutide as a tool that works best alongside consistent nutrition and movement habits. Patients who lose 15 to 20 pounds in the first month but return to unrestricted eating often regain weight despite staying on medication. Those who achieve sustainable monthly losses of 4 to 8 pounds tend to maintain results because they've built healthier patterns alongside pharmacologic support.

Compounded Semaglutide vs. Brand-Name Wegovy Monthly Costs

Brand-name Wegovy is typically priced between $300 and $400 per month depending on dose and location, with many patients requiring insurance coverage or manufacturer discounts to afford treatment. PlexusDx compounded semaglutide injection starts at just $189/mo (or $149/mo on the 6-month plan) from licensed 503A compounding pharmacies, making the same active pharmaceutical ingredient accessible without insurance or membership fees.

Both compounded and brand-name formulations deliver semaglutide and produce comparable weight loss results when dosed appropriately. The key difference is affordability and access—PlexusDx serves all 50 states and accepts HSA and FSA accounts, removing common barriers to consistent monthly treatment. Over a six-month course, choosing compounded semaglutide can save patients between $900 and $1,500 compared to retail Wegovy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I realistically lose in my first month on semaglutide?

Most patients lose 4 to 8 pounds in the first month, with weight loss accelerating as the dose increases every four weeks. Your individual result depends on starting weight, diet adherence, and how your body responds to the medication's appetite-suppressing effects.

Do I continue losing weight every month on semaglutide, or does it plateau?

Weight loss is fastest in months one through three, then typically slows to 2 to 4 pounds per month by month four. Plateaus usually signal that your metabolism has adapted or that calorie intake has drifted; working with your provider to adjust your dose or eating patterns can restart progress.

How much does PlexusDx compounded semaglutide cost compared to Wegovy?

PlexusDx semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) from licensed 503A compounding pharmacies, while Wegovy typically costs $300 to $400 monthly. PlexusDx serves all 50 states without insurance requirements, and your dose can increase without your monthly price increasing.

Is compounded semaglutide as effective as brand-name Wegovy for monthly weight loss?

Yes. Both deliver the same active pharmaceutical ingredient and produce equivalent weight loss results when dosed appropriately. The difference is that PlexusDx compounded semaglutide is more affordable and more widely accessible across all states.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (FTO and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.